Clinical Trials Browser

Neuroendocrine Tumors × IFL protocol × NET × Clear all

NCT05879055 2024-12-19

A Study of PM8002 in Combination With Chemotherapy in Patients With NEN

Phase 2 Recruiting

Neuroendocrine Tumors